France’s Approach to the Opioid Epidemic – Part 3 in a series

In 1987, Health Minister Michèle Barzach imposed the liberalization of syringe sales in France. For a long time, the struggle against HIV rested on this political measure alone. In Europe, buprenorphine for the treatment of opiate addiction was first registered in France and by the year 2000 was available [...]

2020-02-03T16:48:57-06:00February 10th, 2020|

Opioid Limits on Prescribing – Has the Pendulum Swung Too Far?

  I don’t need to quote statistics on opioid misuse disorder to set the tone for this article.  That’s a good thing I guess; it must mean our overall awareness of the topic is current. When I first started talking about this topic at conferences, about 70% of my [...]

2019-09-03T16:07:36-05:00June 6th, 2018|

The True Impact of Case Management

  This week I have been working on CompAlliance’s re-accreditation for Utilization and Case Management, and as a result have been examining in detail our processes, protocols and procedures.  It made me think of an article I recently read on LinkedIn by someone who performs file reviews and analysis [...]

2019-09-03T16:09:28-05:00May 1st, 2018|
Go to Top